All In Biotech

Drug Trial Radar · NCT01674036

Safety, Tolerability and Pharmacokinetics of Genz-682452 in Healthy Men

A Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Ascending Single Oral Doses of Genz-682452 With a Pilot Investigation of Food Effect in Healthy Adult Male Subjects.

Last checked: Nov 19, 2026Latest source record: Mar 19, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

63

Actual

Start

Aug 2012

Primary completion

Jan 2013

Study completion Jan 2013

Sponsor

Lead sponsor
Genzyme, a Sanofi CompanySanofi (SNY)
Sponsor type
Industry
First posted
Aug 28, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
Male only, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The objectives of this study are to assess the tolerability, safety and pharmacokinetic parameters of Genz-682452 in healthy adult males, in two parts. Part 1 (GZFD00111TDU12766): double-blind, randomized, placebo-controlled, sequential ascending single dose study; Part 2 (GZFD00211FED12767): open-label, randomized, 2-sequence, 2-period, 2-treatment crossover study with a minimum wash-out period; to obtain preliminary information on the pharmacokinetics, tolerability and safety of Genz-682452 after single oral doses in fed and fasted conditions. Subjects are not allowed to participate in more than 1 part of the study.

Conditions

  • Healthy Volunteer

Interventions

  • Genz-682452Drug

    Capsules for oral administration.

  • PlaceboDrug

    Placebo to Genz-682452

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with adverse events in Part 1Time frame: Up to 4 weeks
  2. Number of participants with adverse events in Part 2Time frame: Up to 5 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Austin, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.